Nanobiotix S.A.: 5%+ holders

As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Nanobiotix S.A. The largest reported stake is Invus Public Equities, L.P.'s, at 9.4%. 2 filings are on record since July 29, 2026 (Schedule 13G/A, August 13, 2026).

Qatar Investment Authority also filed stake reports on 11 other companies ↓

Sell to companies like Nanobiotix S.A? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Nanobiotix S.A. has 2 Schedule 13D or 13G filings on record since 2026-07-29. 2 holders' latest filing reports 5% or more of ordinary shares, nominal value euro 0.03 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Nanobiotix S.A. and the warning signs.

See Nanobiotix S.A.'s free Snapshot Watch Nanobiotix S.A.: email me the next time it files something

Free to see. No signup.

Keep reading

More on Nanobiotix S.A. and the records around it.

Companies that share a holder

• Qatar Investment Authority also filed stake reports on 11 other companies: Aspen Neuroscience, Inc. (Nov 2026), Global Business Travel Group, Inc. (Sep 2026), West Bay BDC LLC (Jul 2026)
• Invus Public Equities, L.P. also filed stake reports on 24 other companies: City Therapeutics, Inc. (Oct 2026), Yarrow Bioscience, Inc. (Sep 2026), Abivax S.A. (Aug 2026)

Want the whole picture on Nanobiotix S.A.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Nanobiotix S.A.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Nanobiotix S.A. covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies Nanobiotix S.A. by CUSIP 63009J107 and gives its principal executive office as 60 rue de Wattignies, Paris (SCHEDULE 13G/A, 2026-08-13).

What the percentages are based on

As of June 30, 2026, each of the Reporting Persons may be deemed to be the beneficial owner of the percentage of Shares listed on such Reporting Person's cover page.Invus Public Equities, L.P., SCHEDULE 13G/A, 2026-08-13

Timeline

Swipe the table sideways to see every column.

Questions about who owns Nanobiotix S.A.

Who owns Nanobiotix S.A.?

On this page, 2 holders' latest ownership filings report 5% or more of Nanobiotix S.A.: Invus Public Equities, L.P. (9.4%, Schedule 13G/A, filed 2026-08-13) and Qatar Investment Authority (7%, Schedule 13G/A, filed 2026-07-29).

Who are the largest shareholders of Nanobiotix S.A.?

By the share each holder's latest filing reports, the largest holders of Nanobiotix S.A. on this page are Invus Public Equities, L.P. (9.4%) and Qatar Investment Authority (7%).

When did Invus Public Equities, L.P. buy into Nanobiotix S.A.?

The filings give report dates, not purchase dates. The earliest filing from Invus Public Equities, L.P. on this page is the Schedule 13G/A, filed 2026-08-13, reporting 9.4%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 2 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Tools for this story

Each opens in a new tab, filled in for Nanobiotix S.A.. With no account yet, you sign up free and land on the result.

• Get an alert when Nanobiotix S.A. is mentioned again
• Find former Nanobiotix S.A. employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes